Mizuho Medy Co.,Ltd. Stock price

Equities

4595

JP3885900005

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange 02:00:00 2024-03-28 am EDT 5-day change 1st Jan Change
3,255 JPY +0.62% Intraday chart for Mizuho Medy Co.,Ltd. -0.61% +3.66%
Sales 2023 10.99B 72.59M Sales 2024 * 9.5B 62.76M Capitalization 31B 205M
Net income 2023 3.77B 24.93M Net income 2024 * 2.65B 17.51M EV / Sales 2023 2.72 x
Net cash position 2023 * 11.56B 76.4M Net cash position 2024 * 11.47B 75.77M EV / Sales 2024 * 2.06 x
P/E ratio 2023
7.92 x
P/E ratio 2024 *
11.7 x
Employees 175
Yield 2023
6.37%
Yield 2024 *
4.3%
Free-Float 51.17%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.62%
1 week-0.61%
Current month-2.25%
1 month+0.46%
3 months-8.18%
6 months+6.90%
Current year+3.66%
More quotes
1 week
3 195.00
Extreme 3195
3 305.00
1 month
3 195.00
Extreme 3195
3 385.00
Current year
3 105.00
Extreme 3105
3 820.00
1 year
2 010.00
Extreme 2010
3 890.00
3 years
1 774.00
Extreme 1774
4 275.00
5 years
1 024.00
Extreme 1024
4 275.00
10 years
360.00
Extreme 360
4 275.00
More quotes
Managers TitleAgeSince
Founder 79 77-11-01
Chief Tech/Sci/R&D Officer 64 84-03-31
Director/Board Member 60 94-09-30
Members of the board TitleAgeSince
Director/Board Member 78 15-02-28
Founder 79 77-11-01
Chief Tech/Sci/R&D Officer 64 84-03-31
More insiders
Date Price Change Volume
24-03-28 3,255 +0.62% 28 600
24-03-27 3,235 +0.47% 75,800
24-03-26 3,220 -0.31% 57,700
24-03-25 3,230 -0.62% 37,100
24-03-22 3,250 +0.62% 74,300

Delayed Quote Japan Exchange, March 28, 2024 at 02:00 am EDT

More quotes
MIZUHO MEDY CO., LTD. is a Japan-based company principally engaged in-vitro diagnostic pharmaceuticals business. The Company mainly provides in-vitro diagnostic pharmaceuticals, including immune serum test drugs, biochemical test drugs, urine and feces test drugs, microbial test drugs, blood test drugs, pathological test drugs and others, in hospital and medical practitioner fields. In addition, the Company also provides over-the-counter (OTC) drugs to pharmacies and drug stores, and sells fruit tree virus test drugs to which they apply the technology of immune serology test to agricultural test centers.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
  1. Stock
  2. Equities
  3. Stock Mizuho Medy Co.,Ltd. - Japan Exchange